Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cheymol

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Bulletin De L'Academie Nationale De Medecine|October 1, 1990
[Comparison of beta-blocking agents pharmacokinetics in obese and non-obese subjects]G Cheymol
Therapie|July 1, 1992
[Therapeutic follow-up of cyclosporine. Main factors involved in the interpretation of results]G Cheymol
Annales De Gastroenterologie Et D'Hepatologie|June 1, 1987
[Drug administration through the rectum: reliability, tolerance]G Cheymol
Therapie|July 1, 1995
[Therapie 1946-1995: 50 years of publication]G Cheymol
Annales De Gastroenterologie Et D'Hepatologie|March 1, 1993
[Pharmacokinetics and therapeutic monitoring of cyclosporine in liver transplant patients]G Cheymol
Clinical Pharmacokinetics|August 1, 1993
Clinical pharmacokinetics of drugs in obesity. An updateG Cheymol
Fundamental & Clinical Pharmacology|January 1, 1988
Drug pharmacokinetics in the obeseG Cheymol
Bulletin De L'Academie Nationale De Medecine|October 1, 1992
[Pharmacokinetics and therapeutic monitoring of cyclosporine in liver transplant recipients]G Cheymol
Annales De Medecine Interne|January 1, 1987
[Clinical trials of drugs without immediate therapeutic objectives]G Cheymol
Therapie|May 1, 1972
[Neuromuscular, anticholinesterase and pressor effects of quaternary ammonium compounds derived from dicresylphosphate]G Cheymol
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Bulletin De L'Academie Nationale De Medecine|October 1, 1990
[Comparison of beta-blocking agents pharmacokinetics in obese and non-obese subjects]G Cheymol
Therapie|July 1, 1992
[Therapeutic follow-up of cyclosporine. Main factors involved in the interpretation of results]G Cheymol
Annales De Gastroenterologie Et D'Hepatologie|June 1, 1987
[Drug administration through the rectum: reliability, tolerance]G Cheymol
Therapie|July 1, 1995
[Therapie 1946-1995: 50 years of publication]G Cheymol
Annales De Gastroenterologie Et D'Hepatologie|March 1, 1993
[Pharmacokinetics and therapeutic monitoring of cyclosporine in liver transplant patients]G Cheymol
Clinical Pharmacokinetics|August 1, 1993
Clinical pharmacokinetics of drugs in obesity. An updateG Cheymol
Fundamental & Clinical Pharmacology|January 1, 1988
Drug pharmacokinetics in the obeseG Cheymol
Bulletin De L'Academie Nationale De Medecine|October 1, 1992
[Pharmacokinetics and therapeutic monitoring of cyclosporine in liver transplant recipients]G Cheymol
Annales De Medecine Interne|January 1, 1987
[Clinical trials of drugs without immediate therapeutic objectives]G Cheymol
Therapie|May 1, 1972
[Neuromuscular, anticholinesterase and pressor effects of quaternary ammonium compounds derived from dicresylphosphate]G Cheymol
Pageof 15